Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
What to Consider When Doctors Dispense in Work Comp
On average 39% of pharmacy spend comes from non-network dispensing channels.
Genex
White Paper
The Ultimate Guide to Case Management eBook
At Genex, we've always been passionate about advancing the field of case management.
Workers' Comp
Article
Legislative Updates in Workers' Comp: Boosting Industry's Political Voice
In this WCI-TV interview, Brian Allen, VP of Governmental Affairs, offers an update on top regulatory and legislative initiatives that could impact
Workers' Comp
Article
Managing PTSD in Workers' Comp: New Regulations & Best Practices - Interview with Tammy Bradly
In this WCI-TV interview, Enlyte’s Tammy Bradly, Senior Director, Clinical Product Marketing, shares why states are implementing new workers’ comp
Workers' Comp
Podcast
Are All Electronic Provider Payment Solutions the Same?
WorkCompWire
Article